Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
We will not prescribe through the Bridge program without an established clinical relationship and a documented BMI attestation from your provider at the time therapy starts
Driven by a massive, consistent, year-round global market demand within weight management clinics, commercial healthcare networks, and specialized bariatric care centers, this premium localized lipase inhibitor stands as an incredibly stable, high-turnover inventory asset for international B2B buyers and contract distributors
Presented for research literature review only Dalvi SM et al
I cant wait to see the long term results
22.5% PBO-adjusted weight loss at 48 weeks, comparable to retatrutide and ahead of tirzepatide's SURMOUNT-1
US$ 23.98
US$ 27.39
US$ 29.95
US$ 23.76
US$ 21.97
US$ 27.24
US$ 28.11
US$ 26.16
US$ 29.87
